PROCTER & GAMBLE HEALTH | NECTAR LIFESCIENCE | PROCTER & GAMBLE HEALTH/ NECTAR LIFESCIENCE |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 34.6 | 97.7 | 35.4% | View Chart |
P/BV | x | 10.6 | 0.7 | 1,423.3% | View Chart |
Dividend Yield | % | 2.0 | 0.0 | - |
PROCTER & GAMBLE HEALTH NECTAR LIFESCIENCE |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
PROCTER & GAMBLE HEALTH Jun-23 |
NECTAR LIFESCIENCE Mar-23 |
PROCTER & GAMBLE HEALTH/ NECTAR LIFESCIENCE |
5-Yr Chart Click to enlarge
|
||
High | Rs | 5,366 | 34 | 15,734.9% | |
Low | Rs | 3,883 | 14 | 27,040.4% | |
Sales per share (Unadj.) | Rs | 740.7 | 58.0 | 1,277.1% | |
Earnings per share (Unadj.) | Rs | 138.2 | -1.1 | -12,819.2% | |
Cash flow per share (Unadj.) | Rs | 155.2 | 1.6 | 9,960.1% | |
Dividends per share (Unadj.) | Rs | 95.00 | 0 | - | |
Avg Dividend yield | % | 2.1 | 0 | - | |
Book value per share (Unadj.) | Rs | 447.6 | 47.5 | 942.9% | |
Shares outstanding (eoy) | m | 16.60 | 224.26 | 7.4% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 6.2 | 0.4 | 1,494.4% | |
Avg P/E ratio | x | 33.5 | -22.5 | -148.9% | |
P/CF ratio (eoy) | x | 29.8 | 15.6 | 191.6% | |
Price / Book Value ratio | x | 10.3 | 0.5 | 2,023.9% | |
Dividend payout | % | 68.7 | 0 | - | |
Avg Mkt Cap | Rs m | 76,761 | 5,434 | 1,412.6% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 2,062 | 751 | 274.4% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 12,296 | 13,008 | 94.5% | |
Other income | Rs m | 184 | 432 | 42.6% | |
Total revenues | Rs m | 12,480 | 13,440 | 92.9% | |
Gross profit | Rs m | 3,247 | 530 | 612.5% | |
Depreciation | Rs m | 281 | 591 | 47.5% | |
Interest | Rs m | 8 | 795 | 1.0% | |
Profit before tax | Rs m | 3,142 | -424 | -740.7% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 847 | -182 | -464.6% | |
Profit after tax | Rs m | 2,295 | -242 | -948.9% | |
Gross profit margin | % | 26.4 | 4.1 | 648.0% | |
Effective tax rate | % | 27.0 | 43.0 | 62.7% | |
Net profit margin | % | 18.7 | -1.9 | -1,003.8% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 11,713 | 12,312 | 95.1% | |
Current liabilities | Rs m | 6,791 | 8,909 | 76.2% | |
Net working cap to sales | % | 40.0 | 26.2 | 153.0% | |
Current ratio | x | 1.7 | 1.4 | 124.8% | |
Inventory Days | Days | 263 | 56 | 472.9% | |
Debtors Days | Days | 343 | 78 | 437.8% | |
Net fixed assets | Rs m | 10,617 | 9,375 | 113.3% | |
Share capital | Rs m | 166 | 224 | 74.0% | |
"Free" reserves | Rs m | 7,265 | 10,422 | 69.7% | |
Net worth | Rs m | 7,431 | 10,646 | 69.8% | |
Long term debt | Rs m | 0 | 2,265 | 0.0% | |
Total assets | Rs m | 22,330 | 21,686 | 103.0% | |
Interest coverage | x | 409.1 | 0.5 | 87,717.7% | |
Debt to equity ratio | x | 0 | 0.2 | 0.0% | |
Sales to assets ratio | x | 0.6 | 0.6 | 91.8% | |
Return on assets | % | 10.3 | 2.6 | 404.3% | |
Return on equity | % | 30.9 | -2.3 | -1,359.5% | |
Return on capital | % | 42.4 | 2.9 | 1,476.4% | |
Exports to sales | % | 0 | 62.0 | 0.0% | |
Imports to sales | % | 13.1 | 46.2 | 28.2% | |
Exports (fob) | Rs m | NA | 8,064 | 0.0% | |
Imports (cif) | Rs m | 1,605 | 6,012 | 26.7% | |
Fx inflow | Rs m | 1,465 | 8,064 | 18.2% | |
Fx outflow | Rs m | 1,605 | 6,121 | 26.2% | |
Net fx | Rs m | -140 | 1,942 | -7.2% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 2,360 | 1,337 | 176.6% | |
From Investments | Rs m | -215 | 517 | -41.6% | |
From Financial Activity | Rs m | -985 | -1,856 | 53.1% | |
Net Cashflow | Rs m | 1,160 | -2 | -50,890.4% |
Indian Promoters | % | 0.0 | 55.8 | - | |
Foreign collaborators | % | 51.8 | 0.0 | - | |
Indian inst/Mut Fund | % | 20.0 | 17.0 | 117.5% | |
FIIs | % | 6.2 | 17.0 | 36.7% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 48.2 | 44.2 | 109.0% | |
Shareholders | 56,778 | 59,946 | 94.7% | ||
Pledged promoter(s) holding | % | 0.0 | 100.0 | - |
Compare PROCTER & GAMBLE HEALTH With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | Procter & Gamble Health | NECTAR LIFESCIENCE | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -0.43% | 3.07% | 0.45% |
1-Month | -1.15% | 14.55% | 2.55% |
1-Year | 0.73% | 100.00% | 56.14% |
3-Year CAGR | -8.76% | 12.46% | 15.22% |
5-Year CAGR | 4.97% | 15.87% | 19.63% |
* Compound Annual Growth Rate
Here are more details on the Procter & Gamble Health share price and the NECTAR LIFESCIENCE share price.
Moving on to shareholding structures...
The promoters of Procter & Gamble Health hold a 51.8% stake in the company. In case of NECTAR LIFESCIENCE the stake stands at 55.8%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Procter & Gamble Health and the shareholding pattern of NECTAR LIFESCIENCE.
Finally, a word on dividends...
In the most recent financial year, Procter & Gamble Health paid a dividend of Rs 95.0 per share. This amounted to a Dividend Payout ratio of 68.7%.
NECTAR LIFESCIENCE paid Rs 0.0, and its dividend payout ratio stood at -0.0%.
You may visit here to review the dividend history of Procter & Gamble Health, and the dividend history of NECTAR LIFESCIENCE.
For a sector overview, read our pharmaceuticals sector report.
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.